Read More 2 minute read After-Hours Center Cannabis M&A Markets Options Penny Stocks Small Cap Trading Ideas Tilray, KushCo And Aurora Among Top Cannabis Stock Movers On June 28, 2021 By Jose Rodrigo Safdiye Today, 1:53 PM GAINERS: Mexco Energy (AMEX: MXC) shares closed up 14.1% at $10.28 ACB
Read More 1 minute read After-Hours Center Cannabis M&A Markets Cannabis Stock Gainers And Losers From June 25, 2021 By Jose Rodrigo Safdiye Today, 1:53 PM GAINERS: Australis Capital (OTC: AUSAF) shares closed up 33.89% at $0.27 ARNA
Read More 6 minute read Biotech FDA General News Small Cap Top Stories Trading Ideas 14 Biotech Stocks To Watch Over The Next 6 Months By Shanthi Rexaline Today, 1:53 PM Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. AERI
Read More 1 minute read After-Hours Center Cannabis M&A Markets Penny Stocks Small Cap Cannabis Stock Gainers And Losers From June 17, 2021 By Jose Rodrigo Safdiye Today, 1:53 PM GAINERS: Invictus MD Strategies (OTC: IVITF) shares closed up 13.46% at $0.06 ARNA
Read More 1 minute read After-Hours Center Cannabis M&A Markets Penny Stocks Small Cap Cannabis Stock Gainers And Losers From June 10, 2021 By Jose Rodrigo Safdiye Today, 1:53 PM GAINERS: Cipher Pharms Inc (OTC: CPHRF) shares closed up 15,8% at $1,33 ACB
Read More 1 minute read Uncategorized Goldman Sachs Initiates Coverage On Arena Pharmaceuticals with Buy Rating, Announces Price Target of $90 By Benzinga Newsdesk Today, 1:53 PM Goldman Sachs analyst Chris Shibutani initiates coverage on Arena Pharmaceuticals (NASDAQ:ARNA) with a Buy rating and announces Price Target of $90. ARNA
Read More 26 minute read Uncategorized Earnings Scheduled For May 5, 2021 By Benzinga Insights Today, 1:53 PM Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. AAWW
Read More 8 minute read Uncategorized Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge By Shanthi Rexaline Today, 1:53 PM Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. ABUS